229 related articles for article (PubMed ID: 18165848)
1. Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment.
Barrio JR; Kepe V; Satyamurthy N; Huang SC; Small G
J Nutr Health Aging; 2008 Jan; 12(1):61S-5S. PubMed ID: 18165848
[TBL] [Abstract][Full Text] [Related]
2. PET of brain amyloid and tau in mild cognitive impairment.
Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
[TBL] [Abstract][Full Text] [Related]
3. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
4. PET of brain prion protein amyloid in Gerstmann-Sträussler-Scheinker disease.
Kepe V; Ghetti B; Farlow MR; Bresjanac M; Miller K; Huang SC; Wong KP; Murrell JR; Piccardo P; Epperson F; Repovs G; Smid LM; Petric A; Siddarth P; Liu J; Satyamurthy N; Small GW; Barrio JR
Brain Pathol; 2010 Mar; 20(2):419-30. PubMed ID: 19725833
[TBL] [Abstract][Full Text] [Related]
5. Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.
Small GW; Siddarth P; Burggren AC; Kepe V; Ercoli LM; Miller KJ; Lavretsky H; Thompson PM; Cole GM; Huang SC; Phelps ME; Bookheimer SY; Barrio JR
Arch Gen Psychiatry; 2009 Jan; 66(1):81-7. PubMed ID: 19124691
[TBL] [Abstract][Full Text] [Related]
6. Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's disease.
Kuntner C; Kesner AL; Bauer M; Kremslehner R; Wanek T; Mandler M; Karch R; Stanek J; Wolf T; Müller M; Langer O
Mol Imaging Biol; 2009; 11(4):236-40. PubMed ID: 19214638
[TBL] [Abstract][Full Text] [Related]
7. Visualizing pathology deposits in the living brain of patients with Alzheimer's disease.
Kepe V; Huang SC; Small GW; Satyamurthy N; Barrio JR
Methods Enzymol; 2006; 412():144-60. PubMed ID: 17046657
[TBL] [Abstract][Full Text] [Related]
8. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
[TBL] [Abstract][Full Text] [Related]
10. Clinical Relevance of [
Librizzi D; Cabanel N; Zavorotnyy M; Riehl E; Kircher T; Luster M; Hooshyar Yousefi B
Molecules; 2021 Feb; 26(5):. PubMed ID: 33652938
[TBL] [Abstract][Full Text] [Related]
11. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
12. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
[TBL] [Abstract][Full Text] [Related]
13. Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding.
Tolboom N; van der Flier WM; Yaqub M; Boellaard R; Verwey NA; Blankenstein MA; Windhorst AD; Scheltens P; Lammertsma AA; van Berckel BN
J Nucl Med; 2009 Sep; 50(9):1464-70. PubMed ID: 19690025
[TBL] [Abstract][Full Text] [Related]
14. Serotonin 1A receptors in the living brain of Alzheimer's disease patients.
Kepe V; Barrio JR; Huang SC; Ercoli L; Siddarth P; Shoghi-Jadid K; Cole GM; Satyamurthy N; Cummings JL; Small GW; Phelps ME
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):702-7. PubMed ID: 16407119
[TBL] [Abstract][Full Text] [Related]
15. Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction.
Hatashita S; Yamasaki H
PLoS One; 2013; 8(6):e66877. PubMed ID: 23799136
[TBL] [Abstract][Full Text] [Related]
16. Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults.
Lavretsky H; Siddarth P; Kepe V; Ercoli LM; Miller KJ; Burggren AC; Bookheimer SY; Huang SC; Barrio JR; Small GW
Am J Geriatr Psychiatry; 2009 Jun; 17(6):493-502. PubMed ID: 19472439
[TBL] [Abstract][Full Text] [Related]
17. Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imaging.
Ercoli LM; Small GW; Siddarth P; Kepe V; Huang SC; Miller KJ; Lavretsky H; Bookheimer SY; Barrio JR; Silverman DH
Int J Geriatr Psychiatry; 2012 Oct; 27(10):1017-27. PubMed ID: 22383132
[TBL] [Abstract][Full Text] [Related]
18. Dissecting molecular mechanisms in the living brain of dementia patients.
Barrio JR; Satyamurthy N; Huang SC; Petric A; Small GW; Kepe V
Acc Chem Res; 2009 Jul; 42(7):842-50. PubMed ID: 19281227
[TBL] [Abstract][Full Text] [Related]
19. Movement correction method for human brain PET images: application to quantitative analysis of dynamic 18F-FDDNP scans.
Wardak M; Wong KP; Shao W; Dahlbom M; Kepe V; Satyamurthy N; Small GW; Barrio JR; Huang SC
J Nucl Med; 2010 Feb; 51(2):210-8. PubMed ID: 20080894
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET.
Ossenkoppele R; Tolboom N; Foster-Dingley JC; Adriaanse SF; Boellaard R; Yaqub M; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):990-1000. PubMed ID: 22441582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
